Skip to content

Optimal medical therapy (OMT)

DRUG8 trials

Sponsors

Duke University, The University of Texas Health Science Center, Houston, Helios Health Institute GmbH, Charite University, Berlin, Germany, University of Aarhus

Conditions

Coronary Artery DiseaseCoronary Artery Disease (CAD)Heart FailureMitral Valve InsufficiencyMyocardial InfarctionPercutaneous Transluminal AngioplastyRenal Artery Stenosis AtheroscleroticRenovascular Hypertension

Phase 3

Unknown Phase

Combined Pressure and Flow Measurements to Guide Treatment of Coronary Stenoses
CompletedNCT02328820
The University of Texas Health Science Center, HoustonCoronary Artery Disease
Start: 2014-10-31End: 2021-04-30Updated: 2021-04-06
Personalised Risk scOre For Implantation of Defibrillators in Patients With Preserved LVEF>35% and a High Risk for Sudden Cardiac Death
WithdrawnNCT04540289
Helios Health Institute GmbHMyocardial Infarction, Sudden Cardiac Death
Start: 2021-02-01End: 2023-01-31Updated: 2023-03-08
Personalised Risk scOre For Implantation of Defibrillators in Patients With Reduced LVEF≤35% and a Low Risk for Sudden Cardiac Death
WithdrawnNCT04540354
Helios Health Institute GmbHHeart Failure, Myocardial Infarction, Sudden Cardiac Death
Start: 2021-02-01End: 2023-01-31Updated: 2023-03-08
Prevention Of Sudden Cardiac Death After Myocardial Infarction by Defibrillator Implantation
RecruitingNCT05665608
Charite University, Berlin, GermanyMyocardial Infarction, Sudden Cardiac Death
Start: 2023-11-16End: 2027-11-30Target: 3595Updated: 2026-04-01
Effects of Percutaneous Transluminal Renal Angioplasty of Atherosclerotic Renal Artery Stenosis in High-Risk Patients.
RecruitingNCT05834803
University of AarhusHeart Failure, Percutaneous Transluminal Angioplasty, Renal Artery Stenosis Atherosclerotic +2
Start: 2023-06-26End: 2027-06-01Target: 80Updated: 2026-04-23
Micro-axial Flow Pump-Supported PCI in Complex Coronary Artery Disease With Ischemic LV Dysfunction
Not yet recruitingNCT07678021
China National Center for Cardiovascular DiseasesCoronary Artery Disease (CAD)
Start: 2026-08-01End: 2029-12-31Target: 452Updated: 2026-07-01
A Study to Evaluate the Safety and Performance of TruGamma System for Tricuspid Replacement
RecruitingNCT07691307
Jiangsu Trulive Medical Co., LtdTricuspid Valve Disease, Tricuspid Valve Insufficiency, Tricuspid Valve Regurgitation
Start: 2026-03-18End: 2028-08-30Target: 180Updated: 2026-07-08

Related Papers